Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Aballi currently holds 175,000 shares of EXAGEN INC. (XGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Aballi has been a net seller of XGN stock. They have purchased $318.8K and sold $434.9K worth of shares.
John Aballi's most recent insider trade was on Mar 12, 2026, when they sold 100,000 shares at $3.16 per share.
John Aballi serves as Executive at EXAGEN INC. (XGN). They have executed 10 insider transactions totaling $753.7K over their tenure at the company.
John Aballi holds the position of Executive at EXAGEN INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
John Aballi has shown a selling trading pattern, with $318.8K in total purchases and $434.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John Aballi was on Oct 16, 2025, when they sold $375.7K worth of XGN shares. This transaction involved 31,787 shares at $11.82 per share.
John Aballi currently owns 175,000 shares of EXAGEN INC. (XGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Aballi's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Aballi has 10 Form 4 filings on record as an insider at EXAGEN INC..
Set alerts for John Aballi and 40,000+ other insiders.